Search
for
Sort by
Research 151–180 of 227
- Role of Drug Repurposing in Sustainable Drug Discovery
- Hair and diabetes
- Androgenisierung: Diagnostik und Therapie – Akne vulgaris, Hirsutismus, female pattern hair loss
- Ornithine decarboxylase is a target for chemoprevention of basal and squamous cell carcinomas in Ptch1+/– mice
- Polycystic ovary syndrome (PCOS) trilogy: a translational and clinical review
- Minoxidil-induced hypertrichosis: Pathophysiology, clinical implications, and therapeutic strategies
- Hirsutism in a Female Adolescent Induced by Long-Acting Injectable Risperidone
- The first 20 years of skin of color dermatology: An era of advancements in skin, hair, and nail disorders
- Modern Polycystic Ovary Syndrome (PCOS) Management: Intelligent Drug Delivery and Metabolic Reprogramming for Ovarian Restoration and Fertility Optimization
- The remarkable legacy of the K6/ODC mouse: mechanisms of polyamine-promoted tumorigenesis revealed
- The Transgender: Endocrinological Assessment
- Comparative Study of the Therapeutic efficacy of Cyproterone Acetate + Eflornithine (Topical) and Eflornithine (Topical) alone in the Treatment of Facial Hirsutism
- Treatment of hyperandrogenism in polycystic ovary syndrome
- Toward Optimal Health: The Experts Discuss Facial Skin and Related Concerns in Women
- Is topical eflornithine an effective adjunctive therapy in reducing unwanted facial hair in women diagnosed with hirsutism
- Polycystic ovary syndrome
- Therapeutic and skincare products used in hirsutism and hypertrichosis
- Principles of management of women with hirsutism – a dermatologist’s perspective
- An Approach to the Patient With Hirsutism
- Hirsutism and Quality of Life
- Reliability and Validity of a Photographic Method for Measuring Facial Hair Density in Men
- Einfluss von HRT auf Haut und Haare
- A guide to understanding polycystic ovary syndrome (PCOS)
- Randomized, double‐blind clinical evaluation of the efficacy and safety of topical eflornithine HCl 13.9% cream in the treatment of women with facial hair
- Topical Eflornithine
- Vaniqa--eflornithine 13.9% cream.
- Adjuvant eflornithine to maintain IPL‐induced hair reduction in women with facial hirsutism: a randomized controlled trial
- Human Dermal Safety Studies with Eflornithine HCl 13.9% Cream (Vaniqa™), a Novel Treatment for Excessive Facial Hair
- Synergy of Eflornithine Cream with Laser and Light-Based Systems for Hair Management
- Does eflornithine help women face hirsutism?